InsidersTradesSigma
Follow the 카나프테라퓨틱스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has published 19 public disclosures. Market capitalisation: €164.8bn. The latest transaction was reported on 22 May 2026 (Purchase). Among the most active insiders: 김동건. All data is openly available.
18
Insider Decl.
n/a
Thresholds
€334,253
16 ops.
Buy Volume
n/a
1 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 May 2026
Declarations19 total
Other
752,163 sharesKRXDART:20260323000331
5,013,135 sharesKRXDART:20260317000652
ShareKRXDART:20260317000615
19 of 19 declarations
关于 카나프테라퓨틱스
Kanap Therapeutics 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。它专注于开发创新的治疗方法和解决方案。